Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.05 trillion and total revenue of $110.14 billion.
Market Cap
1.05T
Revenue
110.14B
Profits
-41.39B
PE Ratio
n/a
Profit Margin
-37.58%
Dividend Yield
0.05%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.58B | 2.33% | 1,961,009 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.89B | 1.57% | 630,093 | 14.34B |
| 3 | ARGX | argenx SE | 43.57B | 1.87% | 307,546 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.92B | -0.40% | 1,223,873 | 3.71B |
| 5 | INSM | Insmed Incorporated | 33.05B | 5.52% | 4,958,472 | 606.42M |
| 6 | ONC | BeOne Medicines AG | 31.50B | 0.37% | 152,576 | 5.34B |
| 7 | RPRX | Royalty Pharma plc | 26.75B | 0.04% | 2,274,846 | 2.38B |
| 8 | BNTX | BioNTech SE | 20.46B | -0.50% | 583,175 | 3.37B |
| 9 | MRNA | Moderna, Inc. | 19.13B | -2.68% | 5,227,529 | 1.94B |
| 10 | ROIV | Roivant Sciences Ltd. | 18.90B | -0.41% | 4,284,879 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 18.37B | 0.22% | 1,747,130 | - |
| 12 | INCY | Incyte Corporation | 17.98B | 0.03% | 1,535,456 | 5.14B |
| 13 | GMAB | Genmab A/S | 15.88B | 0.04% | 859,279 | 3.72B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 13.45B | -0.49% | 1,554,357 | 502.08M |
| 15 | ASND | Ascendis Pharma A/S | 13.40B | 0.65% | 286,925 | 845.52M |
| 16 | SMMT | Summit Therapeutics Inc. | 13.17B | 2.41% | 2,688,505 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.98B | 0.51% | 2,045,201 | 943.71M |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.59B | -1.05% | 372,685 | 958.40M |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.27B | 0.25% | 478,842 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 10.89B | 1.01% | 2,103,763 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.54B | 1.20% | 999,465 | 3.22B |
| 22 | AXSM | Axsome Therapeutics, Inc. | 8.21B | 2.65% | 517,963 | 638.50M |
| 23 | TECH | Bio-Techne Corporation | 8.14B | 2.14% | 1,757,539 | 1.22B |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.07B | -0.22% | 1,464,983 | 1.09B |
| 25 | ABVX | ABIVAX Société Anonyme | 8.05B | -0.95% | 762,481 | 5.37M |
| 26 | PCVX | Vaxcyte, Inc. | 7.91B | 3.39% | 1,124,591 | - |
| 27 | CYTK | Cytokinetics, Incorporated | 7.76B | 0.75% | 2,443,147 | 88.04M |
| 28 | PRAX | Praxis Precision Medicines, Inc. | 7.70B | -4.71% | 533,854 | 7.46M |
| 29 | NUVL | Nuvalent, Inc. | 7.60B | 0.06% | 719,207 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.36B | 0.81% | 1,109,696 | 1.40B |
| 31 | KRYS | Krystal Biotech, Inc. | 7.22B | 0.63% | 418,508 | 389.13M |
| 32 | IBRX | ImmunityBio, Inc. | 6.85B | -9.76% | 24,495,303 | 113.29M |
| 33 | ACLX | Arcellx, Inc. | 6.73B | 0.17% | 1,242,352 | 22.29M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.49B | 1.69% | 584,733 | 39.21M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.37B | 0.91% | 884,395 | 46.02M |
| 36 | TERN | Terns Pharmaceuticals, Inc. | 5.98B | -0.08% | 7,802,786 | - |
| 37 | BLTE | Belite Bio, Inc | 5.87B | -1.90% | 155,808 | - |
| 38 | APGE | Apogee Therapeutics, Inc. | 5.81B | 1.16% | 988,788 | - |
| 39 | COGT | Cogent Biosciences, Inc. | 5.70B | -1.97% | 1,655,268 | - |
| 40 | PTCT | PTC Therapeutics, Inc. | 5.43B | -0.74% | 930,030 | 1.73B |
| 41 | CGON | CG Oncology, Inc. | 5.40B | -1.02% | 957,756 | 4.04M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 5.30B | -0.61% | 2,076,145 | 521.31M |
| 43 | XENE | Xenon Pharmaceuticals Inc. | 5.30B | 1.96% | 1,051,598 | 7.50M |
| 44 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.28B | 1.89% | 1,259,801 | 189.76M |
| 45 | CELC | Celcuity Inc. | 5.23B | 2.12% | 553,848 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 4.95B | 1.13% | 777,903 | - |
| 47 | IMVT | Immunovant, Inc. | 4.79B | -1.79% | 1,157,494 | - |
| 48 | CAI | Caris Life Sciences, Inc. | 4.76B | -0.59% | 2,309,953 | 812.03M |
| 49 | TGTX | TG Therapeutics, Inc. | 4.65B | -0.76% | 1,645,239 | 616.29M |
| 50 | ERAS | Erasca, Inc. | 4.64B | -0.20% | 5,229,250 | - |
| 51 | FOLD | Amicus Therapeutics, Inc. | 4.53B | 0.14% | 1,482,289 | 634.21M |
| 52 | CRSP | CRISPR Therapeutics AG | 4.26B | -3.08% | 1,617,389 | 3.51M |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 4.21B | -2.07% | 962,351 | 2.04M |
| 54 | CORT | Corcept Therapeutics Incorporated | 4.05B | 1.38% | 1,956,327 | 761.41M |
| 55 | CNTA | Centessa Pharmaceuticals plc | 4.03B | -3.90% | 1,689,254 | 15.00M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 3.84B | -1.45% | 215,365 | 268.09M |
| 57 | ACAD | ACADIA Pharmaceuticals Inc. | 3.59B | 1.54% | 1,723,976 | 1.07B |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.59B | 1.78% | 1,114,366 | 7.70M |
| 59 | SYRE | Spyre Therapeutics, Inc. | 3.57B | -3.99% | 712,469 | - |
| 60 | VKTX | Viking Therapeutics, Inc. | 3.46B | -8.00% | 3,189,867 | - |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 3.37B | -2.17% | 504,920 | 22.50M |
| 62 | EWTX | Edgewise Therapeutics, Inc. | 3.25B | -1.82% | 614,234 | - |
| 63 | LEGN | Legend Biotech Corporation | 3.20B | 3.04% | 1,544,812 | 1.03B |
| 64 | GPCR | Structure Therapeutics Inc. | 3.11B | -4.31% | 1,006,141 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.03B | -2.61% | 171,862 | 803.79M |
| 66 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.90B | 1.62% | 802,726 | 588.99M |
| 67 | DNLI | Denali Therapeutics Inc. | 2.87B | -0.44% | 1,733,974 | - |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 2.85B | 1.01% | 362,293 | 451.36M |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.82B | -0.29% | 1,702,215 | - |
| 70 | IDYA | IDEAYA Biosciences, Inc. | 2.76B | 3.25% | 649,170 | 218.71M |
| 71 | TNGX | Tango Therapeutics, Inc. | 2.74B | -0.26% | 2,319,191 | 62.38M |
| 72 | VERA | Vera Therapeutics, Inc. | 2.72B | -1.96% | 426,016 | - |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 2.65B | 0.52% | 1,313,814 | 376.07M |
| 74 | RCUS | Arcus Biosciences, Inc. | 2.59B | 1.82% | 718,094 | 247.00M |
| 75 | ALMS | Alumis Inc. | 2.57B | -18.51% | 5,585,402 | 24.05M |
| 76 | TVTX | Travere Therapeutics, Inc. | 2.55B | 1.50% | 1,031,567 | 490.73M |
| 77 | IRON | Disc Medicine, Inc. | 2.32B | 1.15% | 595,690 | - |
| 78 | MANE | Veradermics, Incorporated | 2.27B | -7.14% | 599,549 | - |
| 79 | ORKA | Oruka Therapeutics, Inc. | 2.26B | 2.34% | 827,138 | - |
| 80 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | 0.05% | 1,254,413 | 158.18M |
| 81 | AAPG | Ascentage Pharma Group International | 2.19B | 0.48% | 1,202 | 82.08M |
| 82 | ELVN | Enliven Therapeutics, Inc. | 2.19B | -5.77% | 2,004,290 | - |
| 83 | APLS | Apellis Pharmaceuticals, Inc. | 2.18B | 0.71% | 2,165,368 | 1.00B |
| 84 | IMNM | Immunome, Inc. | 2.18B | -1.58% | 1,065,476 | 6.94M |
| 85 | ADMA | ADMA Biologics, Inc. | 2.18B | -1.08% | 8,056,033 | 510.17M |
| 86 | BEAM | Beam Therapeutics Inc. | 2.17B | -1.31% | 2,264,377 | 139.74M |
| 87 | SRPT | Sarepta Therapeutics, Inc. | 2.15B | 2.55% | 2,923,721 | 2.20B |
| 88 | KOD | Kodiak Sciences Inc. | 2.09B | -9.03% | 2,346,052 | - |
| 89 | ZLAB | Zai Lab Limited | 2.01B | -0.83% | 383,842 | 460.16M |
| 90 | SNDX | Syndax Pharmaceuticals, Inc. | 1.98B | -4.30% | 1,538,936 | 172.35M |
| 91 | ADPT | Adaptive Biotechnologies Corporation | 1.98B | 3.55% | 1,819,357 | 276.98M |
| 92 | CLDX | Celldex Therapeutics, Inc. | 1.96B | -2.71% | 650,110 | 1.55M |
| 93 | MLYS | Mineralys Therapeutics, Inc. | 1.94B | -0.72% | 997,792 | - |
| 94 | GLPG | Galapagos NV | 1.92B | -0.31% | 134,603 | 1.31B |
| 95 | VRDN | Viridian Therapeutics, Inc. | 1.89B | -32.35% | 13,775,917 | 70.85M |
| 96 | RARE | Ultragenyx Pharmaceutical Inc. | 1.89B | -0.41% | 3,655,358 | 673.00M |
| 97 | MESO | Mesoblast Limited | 1.89B | 0.07% | 178,684 | 65.38M |
| 98 | STOK | Stoke Therapeutics, Inc. | 1.88B | -3.29% | 480,049 | 184.42M |
| 99 | NKTR | Nektar Therapeutics | 1.87B | -4.97% | 1,105,079 | 55.23M |
| 100 | TYRA | Tyra Biosciences, Inc. | 1.86B | -4.66% | 1,541,051 | - |
| 101 | AUPH | Aurinia Pharmaceuticals Inc. | 1.86B | -2.03% | 1,334,123 | 283.06M |
| 102 | ZYME | Zymeworks Inc. | 1.79B | 0.12% | 596,663 | 105.97M |
| 103 | PHVS | Pharvaris N.V. | 1.77B | -0.33% | 216,183 | - |
| 104 | DFTX | Definium Therapeutics, Inc. | 1.74B | -2.13% | 1,615,336 | - |
| 105 | AGIO | Agios Pharmaceuticals, Inc. | 1.73B | 0.61% | 821,013 | 54.03M |
| 106 | INVA | Innoviva, Inc. | 1.70B | 1.10% | 2,035,092 | 411.33M |
| 107 | RLAY | Relay Therapeutics, Inc. | 1.67B | -2.60% | 1,568,291 | 15.36M |
| 108 | SION | Sionna Therapeutics, Inc. | 1.65B | 1.38% | 344,230 | - |
| 109 | OCUL | Ocular Therapeutix, Inc. | 1.61B | -1.99% | 3,140,861 | 51.95M |
| 110 | CAPR | Capricor Therapeutics, Inc. | 1.60B | -3.91% | 745,372 | 11.13M |
| 111 | ANAB | AnaptysBio, Inc. | 1.59B | -3.50% | 957,179 | 234.60M |
| 112 | SLNO | Soleno Therapeutics, Inc. | 1.57B | 1.30% | 1,393,349 | 190.41M |
| 113 | VCEL | Vericel Corporation | 1.56B | 4.12% | 916,278 | 276.26M |
| 114 | HRMY | Harmony Biosciences Holdings, Inc. | 1.56B | 1.36% | 628,727 | 868.45M |
| 115 | NRIX | Nurix Therapeutics, Inc. | 1.52B | -0.61% | 1,036,653 | 83.98M |
| 116 | RXRX | Recursion Pharmaceuticals, Inc. | 1.50B | -3.40% | 16,862,481 | 74.68M |
| 117 | NBTX | Nanobiotix S.A. | 1.50B | 2.10% | 63,352 | 11.93M |
| 118 | PVLA | Palvella Therapeutics, Inc. | 1.49B | -1.52% | 281,730 | - |
| 119 | IMCR | Immunocore Holdings plc | 1.48B | -0.51% | 318,824 | 400.02M |
| 120 | GENB | Generate Biomedicines, Inc. | 1.47B | 0.61% | 227,048 | 31.89M |
| 121 | DMRA | Damora Therapeutics, Inc. | 1.46B | -4.82% | 240,980 | - |
| 122 | OCS | Oculis Holding AG | 1.45B | -0.57% | 219,112 | 1.51M |
| 123 | MAZE | Maze Therapeutics, Inc. | 1.44B | -4.51% | 1,057,438 | 2.50M |
| 124 | TRVI | Trevi Therapeutics, Inc. | 1.44B | -1.24% | 962,209 | - |
| 125 | NUVB | Nuvation Bio Inc. | 1.39B | -4.71% | 3,546,446 | 62.90M |
| 126 | NTLA | Intellia Therapeutics, Inc. | 1.38B | -5.82% | 3,620,420 | 67.67M |
| 127 | IOVA | Iovance Biotherapeutics, Inc. | 1.37B | -5.41% | 9,934,644 | 263.50M |
| 128 | ARDX | Ardelyx, Inc. | 1.36B | 1.28% | 2,585,053 | 407.32M |
| 129 | VIR | Vir Biotechnology, Inc. | 1.35B | 0.71% | 1,487,822 | 68.56M |
| 130 | RAPP | Rapport Therapeutics, Inc. | 1.32B | -0.54% | 346,981 | - |
| 131 | NVAX | Novavax, Inc. | 1.32B | -4.26% | 4,152,388 | 1.12B |
| 132 | MBX | MBX Biosciences, Inc. | 1.28B | -5.54% | 452,861 | - |
| 133 | SVRA | Savara Inc. | 1.28B | -1.75% | 1,195,244 | - |
| 134 | IMTX | Immatics N.V. | 1.25B | -0.75% | 186,915 | 56.67M |
| 135 | WVE | Wave Life Sciences Ltd. | 1.25B | 3.92% | 6,288,690 | 42.73M |
| 136 | GLUE | Monte Rosa Therapeutics, Inc. | 1.24B | 0.98% | 1,008,045 | 123.67M |
| 137 | ATAI | AtaiBeckley Inc. | 1.24B | 1.49% | 2,956,979 | 4.09M |
| 138 | BCAX | Bicara Therapeutics Inc. | 1.24B | 3.65% | 971,429 | - |
| 139 | ORIC | ORIC Pharmaceuticals, Inc. | 1.22B | 1.08% | 1,394,997 | - |
| 140 | BHVN | Biohaven Ltd. | 1.22B | -3.35% | 2,077,771 | - |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.21B | -2.25% | 1,339,478 | - |
| 142 | OLMA | Olema Pharmaceuticals, Inc. | 1.17B | -1.83% | 990,450 | - |
| 143 | TSHA | Taysha Gene Therapies, Inc. | 1.17B | - | 2,317,049 | 9.77M |
| 144 | PGEN | Precigen, Inc. | 1.15B | -11.44% | 13,128,048 | 9.68M |
| 145 | CRVS | Corvus Pharmaceuticals, Inc. | 1.13B | -4.35% | 1,320,532 | - |
| 146 | DBVT | DBV Technologies S.A. | 1.12B | -2.20% | 201,174 | 5.64M |
| 147 | PHAR | Pharming Group N.V. | 1.11B | -1.84% | 16,686 | 376.13M |
| 148 | ZBIO | Zenas BioPharma, Inc. | 1.08B | 0.08% | 1,201,550 | 10.00M |
| 149 | IVA | Inventiva S.A. | 1.05B | -4.20% | 286,516 | 19.93M |
| 150 | SEPN | Septerna, Inc. | 1.05B | -2.39% | 223,281 | 45.95M |
| 151 | ABCL | AbCellera Biologics Inc. | 994.37M | 0.31% | 2,830,670 | 75.13M |
| 152 | EYPT | EyePoint, Inc. | 988.67M | -5.20% | 792,193 | 31.37M |
| 153 | XERS | Xeris Biopharma Holdings, Inc. | 965.62M | 3.70% | 2,541,908 | 291.85M |
| 154 | CTMX | CytomX Therapeutics, Inc. | 953.34M | -2.43% | 4,043,921 | 76.20M |
| 155 | KALV | KalVista Pharmaceuticals, Inc. | 940.44M | -5.02% | 1,468,143 | 73.62M |
| 156 | AVBP | ArriVent BioPharma, Inc. | 928.68M | -1.96% | 308,160 | - |
| 157 | QURE | uniQure N.V. | 921.06M | -0.27% | 1,135,157 | 16.10M |
| 158 | CMPX | Compass Therapeutics, Inc. | 918.45M | -2.11% | 1,281,286 | 850.00K |
| 159 | GERN | Geron Corporation | 903.17M | 0.71% | 16,680,009 | 183.88M |
| 160 | INBX | Inhibrx Biosciences, Inc. | 874.67M | 2.55% | 180,269 | 1.30M |
| 161 | AKTS | Aktis Oncology, Inc. | 868.72M | 8.89% | 452,258 | 6.50M |
| 162 | ABUS | Arbutus Biopharma Corporation | 840.56M | 0.23% | 1,117,270 | 14.08M |
| 163 | XNCR | Xencor, Inc. | 832.39M | -0.61% | 938,483 | 125.58M |
| 164 | PHAT | Phathom Pharmaceuticals, Inc. | 829.75M | -0.47% | 1,336,523 | 175.11M |
| 165 | FTRE | Fortrea Holdings Inc. | 829.35M | -2.21% | 1,143,523 | 2.72B |
| 166 | URGN | UroGen Pharma Ltd. | 827.60M | -0.99% | 1,059,318 | 109.79M |
| 167 | MPLT | MapLight Therapeutics, Inc. | 823.69M | 0.86% | 241,510 | - |
| 168 | CGEM | Cullinan Therapeutics, Inc. | 812.26M | 4.44% | 730,597 | - |
| 169 | GHRS | GH Research PLC | 808.24M | -0.91% | 114,369 | - |
| 170 | JANX | Janux Therapeutics, Inc. | 792.64M | -1.14% | 840,241 | 10.00M |
| 171 | EVMN | Evommune, Inc. | 792.40M | -0.81% | 153,282 | 13.00M |
| 172 | TBPH | Theravance Biopharma, Inc. | 785.78M | 1.19% | 570,336 | 107.46M |
| 173 | SGP | SpyGlass Pharma, Inc. | 778.63M | 3.36% | 67,792 | - |
| 174 | SPRY | ARS Pharmaceuticals, Inc. | 776.01M | -3.16% | 1,075,240 | 84.28M |
| 175 | MRVI | Maravai LifeSciences Holdings, Inc. | 740.35M | 0.70% | 930,221 | 185.74M |
| 176 | ANNX | Annexon, Inc. | 739.32M | -0.80% | 2,293,853 | - |
| 177 | MNKD | MannKind Corporation | 730.20M | 3.95% | 5,514,329 | 348.97M |
| 178 | SLS | SELLAS Life Sciences Group, Inc. | 719.23M | -8.25% | 8,664,720 | - |
| 179 | SANA | Sana Biotechnology, Inc. | 715.20M | -3.25% | 3,346,957 | - |
| 180 | TENX | Tenax Therapeutics, Inc. | 704.71M | -5.97% | 253,851 | - |
| 181 | OMER | Omeros Corporation | 695.53M | -0.71% | 1,081,755 | - |
| 182 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 694.68M | -2.25% | 122,561 | - |
| 183 | KURA | Kura Oncology, Inc. | 682.79M | -0.13% | 1,207,343 | 67.48M |
| 184 | DRUG | Bright Minds Biosciences Inc. | 670.65M | -2.35% | 178,244 | - |
| 185 | RLMD | Relmada Therapeutics, Inc. | 669.20M | -0.78% | 750,543 | - |
| 186 | MGTX | MeiraGTx Holdings plc | 658.90M | 6.17% | 1,386,550 | 81.39M |
| 187 | JBIO | Jade Biosciences, Inc. | 653.93M | -0.97% | 242,824 | - |
| 188 | ARVN | Arvinas, Inc. | 651.12M | 0.79% | 633,165 | 262.60M |
| 189 | LXRX | Lexicon Pharmaceuticals, Inc. | 639.76M | -8.48% | 3,358,250 | 49.80M |
| 190 | DSGN | Design Therapeutics, Inc. | 639.54M | -1.52% | 183,373 | - |
| 191 | SLDB | Solid Biosciences Inc. | 638.56M | -8.72% | 1,242,294 | - |
| 192 | ANRO | Alto Neuroscience, Inc. | 638.27M | -2.54% | 174,754 | - |
| 193 | GYRE | Gyre Therapeutics, Inc. | 624.59M | 0.88% | 104,347 | 116.59M |
| 194 | VOR | Vor Biopharma Inc. | 610.34M | 1.52% | 1,073,634 | - |
| 195 | REPL | Replimune Group, Inc. | 594.52M | -0.28% | 1,348,007 | - |
| 196 | OCGN | Ocugen, Inc. | 591.32M | -6.42% | 7,310,111 | 4.41M |
| 197 | LBRX | LB Pharmaceuticals Inc | 588.20M | -2.47% | 108,767 | - |
| 198 | DRTS | Alpha Tau Medical Ltd. | 576.46M | -4.52% | 243,224 | - |
| 199 | MDXG | MiMedx Group, Inc. | 573.47M | 1.31% | 923,682 | 418.63M |
| 200 | YDES | YD Bio Limited | 569.59M | 3.71% | 25,856 | 510.36K |
| 201 | PRME | Prime Medicine, Inc. | 557.80M | -6.80% | 3,919,405 | 4.63M |
| 202 | VALN | Valneva SE | 556.03M | 1.05% | 149,864 | 205.07M |
| 203 | CBIO | Crescent Biopharma, Inc. | 552.01M | 9.63% | 275,016 | 10.84M |
| 204 | TECX | Tectonic Therapeutic, Inc. | 542.08M | -1.64% | 230,124 | - |
| 205 | ALLO | Allogene Therapeutics, Inc. | 541.19M | -1.77% | 4,555,889 | 22.00K |
| 206 | ZURA | Zura Bio Limited | 538.92M | -4.22% | 596,529 | - |
| 207 | EIKN | Eikon Therapeutics, Inc. | 522.57M | -1.33% | 299,387 | - |
| 208 | CRMD | CorMedix Inc. | 519.36M | -2.09% | 1,340,718 | 311.71M |
| 209 | ZVRA | Zevra Therapeutics, Inc. | 515.49M | -4.15% | 904,780 | 106.47M |
| 210 | PRTA | Prothena Corporation plc | 497.96M | -0.11% | 416,146 | 9.68M |
| 211 | PROK | ProKidney Corp. | 489.10M | 1.25% | 947,674 | 893.00K |
| 212 | ACRS | Aclaris Therapeutics, Inc. | 485.09M | -0.85% | 1,519,891 | 7.83M |
| 213 | AGMB | AgomAb Therapeutics NV | 480.54M | -9.12% | 117,583 | - |
| 214 | UPB | Upstream Bio, Inc. | 477.81M | 1.27% | 863,154 | 2.85M |
| 215 | RIGL | Rigel Pharmaceuticals, Inc. | 475.13M | -0.35% | 228,863 | 294.28M |
| 216 | FBRX | Forte Biosciences, Inc. | 469.32M | 3.22% | 439,892 | - |
| 217 | CTNM | Contineum Therapeutics, Inc. | 465.21M | -6.60% | 190,100 | - |
| 218 | ADCT | ADC Therapeutics SA | 462.44M | -1.62% | 678,671 | 81.36M |
| 219 | KYTX | Kyverna Therapeutics, Inc. | 458.25M | -2.82% | 716,173 | - |
| 220 | VTVT | vTv Therapeutics Inc. | 455.43M | -4.70% | 29,268 | 17.00K |
| 221 | IMMX | Immix Biopharma, Inc. | 454.44M | 5.28% | 912,319 | - |
| 222 | LYEL | Lyell Immunopharma, Inc. | 449.59M | -1.93% | 53,145 | 36.00K |
| 223 | LRMR | Larimar Therapeutics, Inc. | 447.74M | -6.71% | 1,153,745 | - |
| 224 | FULC | Fulcrum Therapeutics, Inc. | 438.23M | -2.23% | 559,461 | 80.00M |
| 225 | FDMT | 4D Molecular Therapeutics, Inc. | 437.51M | -8.15% | 1,176,003 | 85.21M |
| 226 | NAUT | Nautilus Biotechnology, Inc. | 434.12M | -1.44% | 289,854 | - |
| 227 | STTK | Shattuck Labs, Inc. | 426.52M | -1.00% | 288,773 | 1.00M |
| 228 | VSTM | Verastem, Inc. | 426.00M | -3.77% | 2,318,929 | 30.91M |
| 229 | TRDA | Entrada Therapeutics, Inc. | 423.72M | -1.34% | 243,595 | 25.42M |
| 230 | ASMB | Assembly Biosciences, Inc. | 422.58M | -3.83% | 72,596 | 72.30M |
| 231 | ABSI | Absci Corporation | 422.34M | -0.72% | 3,563,020 | 2.80M |
| 232 | ENGN | enGene Holdings Inc. | 413.99M | -2.98% | 140,079 | - |
| 233 | EPRX | Eupraxia Pharmaceuticals Inc. | 410.80M | -1.64% | 86,785 | - |
| 234 | AVIR | Atea Pharmaceuticals, Inc. | 404.73M | -0.78% | 304,147 | - |
| 235 | RGNX | REGENXBIO Inc. | 401.03M | 0.13% | 619,998 | 170.44M |
| 236 | STRO | Sutro Biopharma, Inc. | 399.27M | -1.35% | 73,433 | 102.48M |
| 237 | AURA | Aura Biosciences, Inc. | 397.73M | -1.12% | 295,020 | - |
| 238 | VNDA | Vanda Pharmaceuticals Inc. | 393.07M | -3.76% | 1,166,134 | 216.11M |
| 239 | LXEO | Lexeo Therapeutics, Inc. | 384.64M | -3.48% | 828,099 | - |
| 240 | ALT | Altimmune, Inc. | 374.70M | -4.64% | 3,116,108 | 41.00K |
| 241 | RCKT | Rocket Pharmaceuticals, Inc. | 374.02M | -8.62% | 9,910,652 | - |
| 242 | LCTX | Lineage Cell Therapeutics, Inc. | 366.16M | -1.34% | 900,887 | 14.56M |
| 243 | IPSC | Century Therapeutics, Inc. | 364.84M | 0.50% | 1,408,247 | 109.16M |
| 244 | XFOR | X4 Pharmaceuticals, Inc. | 362.77M | -1.24% | 358,508 | 35.11M |
| 245 | XOMA | XOMA Royalty Corporation | 360.15M | 0.20% | 76,543 | 52.15M |
| 246 | MNPR | Monopar Therapeutics Inc. | 356.11M | -1.50% | 113,411 | - |
| 247 | DMAC | DiaMedica Therapeutics Inc. | 355.76M | -2.21% | 343,857 | - |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 353.46M | - | 126,890 | 66.98M |
| 249 | PRTC | PureTech Health plc | 346.23M | -5.72% | 12,576 | 6.39M |
| 250 | BNTC | Benitec Biopharma Inc. | 344.60M | -2.04% | 100,507 | - |
| 251 | NAGE | Niagen Bioscience, Inc. | 343.46M | 1.90% | 1,009,493 | 129.42M |
| 252 | AUTL | Autolus Therapeutics plc | 338.00M | 4.96% | 1,929,218 | 75.39M |
| 253 | IVVD | Invivyd, Inc. | 336.29M | -13.14% | 5,682,246 | 53.43M |
| 254 | CADL | Candel Therapeutics, Inc. | 328.15M | -6.86% | 1,199,887 | - |
| 255 | NMRA | Neumora Therapeutics, Inc. | 327.98M | -17.17% | 2,792,169 | - |
| 256 | DNA | Ginkgo Bioworks Holdings, Inc. | 318.98M | -7.59% | 2,116,324 | 170.16M |
| 257 | AVTX | Avalo Therapeutics, Inc. | 317.44M | 0.29% | 519,719 | 59.00K |
| 258 | IMRX | Immuneering Corporation | 315.51M | -1.61% | 581,097 | - |
| 259 | SRZN | Surrozen, Inc. | 315.31M | -5.02% | 34,306 | 3.48M |
| 260 | ARMP | Armata Pharmaceuticals, Inc. | 314.68M | 2.63% | 29,197 | 4.90M |
| 261 | PLYX | Polaryx Therapeutics, Inc. | 312.94M | -15.15% | 663,835 | - |
| 262 | CLYM | Climb Bio, Inc. | 312.40M | -6.84% | 307,447 | - |
| 263 | PBYI | Puma Biotechnology, Inc. | 311.87M | 0.82% | 182,783 | 228.37M |
| 264 | IRD | Opus Genetics, Inc. | 309.50M | - | 461,982 | 14.20M |
| 265 | BCYC | Bicycle Therapeutics plc | 302.53M | 0.70% | 238,435 | 72.59M |
| 266 | NGNE | Neurogene Inc. | 300.58M | -5.16% | 169,389 | 925.00K |
| 267 | GLSI | Greenwich LifeSciences, Inc. | 297.73M | -3.76% | 162,305 | - |
| 268 | NGEN | NervGen Pharma Corp. | 297.09M | 1.91% | 68,068 | - |
| 269 | RZLT | Rezolute, Inc. | 296.04M | -4.68% | 1,489,751 | - |
| 270 | PALI | Palisade Bio, Inc. | 295.27M | -11.00% | 8,826,264 | - |
| 271 | PEPG | PepGen Inc. | 292.36M | -6.42% | 1,761,064 | - |
| 272 | OVID | Ovid Therapeutics Inc. | 278.26M | -8.26% | 2,820,636 | 7.25M |
| 273 | CABA | Cabaletta Bio, Inc. | 274.97M | -7.84% | 2,429,256 | - |
| 274 | IKT | Inhibikase Therapeutics, Inc. | 269.27M | -5.95% | 897,306 | 1.00 |
| 275 | SABS | SAB Biotherapeutics, Inc. | 265.64M | -1.82% | 444,786 | 114.70K |
| 276 | TARA | Protara Therapeutics, Inc. | 262.31M | -1.82% | 513,477 | - |
| 277 | AVXL | Anavex Life Sciences Corp. | 261.33M | - | 1,570,184 | - |
| 278 | LENZ | LENZ Therapeutics, Inc. | 259.93M | -1.31% | 1,280,412 | 19.09M |
| 279 | FHTX | Foghorn Therapeutics Inc. | 259.46M | -1.78% | 171,638 | 30.91M |
| 280 | NERV | Minerva Neurosciences, Inc. | 258.35M | -3.40% | 148,826 | - |
| 281 | NBP | NovaBridge Biosciences | 258.25M | -11.81% | 2,557,710 | - |
| 282 | ACIU | AC Immune SA | 253.95M | -5.19% | 291,667 | 4.51M |
| 283 | PRLD | Prelude Therapeutics Incorporated | 253.38M | 0.66% | 176,047 | 12.14M |
| 284 | ALXO | ALX Oncology Holdings Inc. | 251.37M | -6.37% | 768,036 | - |
| 285 | ANL | Adlai Nortye Ltd. | 243.91M | 2.32% | 87,140 | -1.35M |
| 286 | ABEO | Abeona Therapeutics Inc. | 241.32M | -1.40% | 874,634 | 5.82M |
| 287 | CHRS | Coherus Oncology, Inc. | 239.82M | -1.84% | 806,378 | 42.17M |
| 288 | OBIO | Orchestra BioMed Holdings, Inc. | 238.18M | -4.46% | 149,861 | 33.48M |
| 289 | SLN | Silence Therapeutics plc | 235.23M | 1.01% | 292,441 | 559.00K |
| 290 | CLLS | Cellectis S.A. | 233.21M | 0.65% | 17,199 | 79.59M |
| 291 | VYGR | Voyager Therapeutics, Inc. | 230.65M | -2.27% | 735,007 | 40.37M |
| 292 | CCCC | C4 Therapeutics, Inc. | 229.31M | -2.49% | 720,689 | 35.95M |
| 293 | OABI | OmniAb, Inc. | 225.86M | 3.31% | 199,201 | 18.67M |
| 294 | CNTX | Context Therapeutics Inc. | 225.10M | -5.41% | 391,677 | - |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 224.06M | -13.46% | 53,701 | 19.39M |
| 296 | ALEC | Alector, Inc. | 222.93M | 1.00% | 384,066 | 21.05M |
| 297 | EDIT | Editas Medicine, Inc. | 218.25M | - | 1,774,715 | 40.52M |
| 298 | HELP | Cybin Inc. | 216.15M | -4.42% | 682,564 | - |
| 299 | ENLV | Enlivex Ltd. | 213.64M | -14.29% | 379,348 | - |
| 300 | KROS | Keros Therapeutics, Inc. | 210.58M | 0.66% | 396,531 | 244.06M |
| 301 | CAMP | Camp4 Therapeutics Corporation | 207.68M | -7.19% | 112,517 | 3.50M |
| 302 | ELDN | Eledon Pharmaceuticals, Inc. | 205.87M | -4.24% | 1,032,832 | - |
| 303 | FENC | Fennec Pharmaceuticals Inc. | 198.92M | -2.37% | 205,065 | 44.64M |
| 304 | MDWD | MediWound Ltd. | 198.59M | 2.72% | 124,220 | 16.96M |
| 305 | NVCT | Nuvectis Pharma, Inc. | 198.42M | 0.13% | 97,712 | - |
| 306 | ARCT | Arcturus Therapeutics Holdings Inc. | 196.12M | 2.07% | 661,043 | 82.03M |
| 307 | CGEN | Compugen Ltd. | 188.16M | -2.45% | 189,801 | 72.76M |
| 308 | ELTX | Elicio Therapeutics, Inc. | 185.43M | -3.45% | 175,720 | - |
| 309 | ADAG | Adagene Inc. | 178.63M | 0.53% | 41,183 | 103.20K |
| 310 | MGNX | MacroGenics, Inc. | 175.41M | -5.80% | 568,225 | 149.50M |
| 311 | TNXP | Tonix Pharmaceuticals Holding Corp. | 170.89M | -6.60% | 757,343 | 13.11M |
| 312 | PLX | Protalix BioTherapeutics, Inc. | 168.39M | -2.34% | 1,069,981 | 52.74M |
| 313 | CRBU | Caribou Biosciences, Inc. | 166.22M | -3.37% | 1,272,277 | 11.16M |
| 314 | GALT | Galectin Therapeutics Inc. | 165.70M | -4.10% | 189,806 | - |
| 315 | CNTB | Connect Biopharma Holdings Limited | 162.12M | -15.94% | 1,519,532 | 762.00K |
| 316 | PRQR | ProQR Therapeutics N.V. | 159.10M | 10.22% | 1,693,484 | 19.19M |
| 317 | CNTN | Canton Strategic Holdings, Inc. | 158.68M | -2.84% | 499,868 | - |
| 318 | TLSA | Tiziana Life Sciences Ltd | 158.25M | - | 208,202 | - |
| 319 | ABOS | Acumen Pharmaceuticals, Inc. | 158.15M | -3.10% | 447,078 | - |
| 320 | RNAC | Cartesian Therapeutics, Inc. | 155.87M | 0.51% | 154,155 | 2.80M |
| 321 | WHWK | Whitehawk Therapeutics, Inc. | 154.80M | 3.80% | 209,570 | 7.15M |
| 322 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 152.53M | -1.26% | 146,960 | - |
| 323 | KRRO | Korro Bio, Inc. | 148.26M | -1.15% | 245,459 | 6.39M |
| 324 | SGMT | Sagimet Biosciences Inc. | 148.26M | -6.95% | 599,192 | - |
| 325 | MOLN | Molecular Partners AG | 146.79M | -3.03% | 2,744 | 856.30K |
| 326 | MENS | Jyong Biotech Ltd. | 146.11M | -2.06% | 183,519 | - |
| 327 | NKTX | Nkarta, Inc. | 142.58M | -2.91% | 568,555 | - |
| 328 | ACHV | Achieve Life Sciences, Inc. | 142.15M | 0.75% | 535,714 | - |
| 329 | HRTX | Heron Therapeutics, Inc. | 140.63M | -4.82% | 1,534,162 | 154.90M |
| 330 | NTHI | NeOnc Technologies Holdings, Inc. | 140.11M | -3.71% | 25,670 | 59.99K |
| 331 | DTIL | Precision BioSciences, Inc. | 139.85M | -9.97% | 249,386 | 34.26M |
| 332 | CBUS | Cibus, Inc. | 138.63M | -3.19% | 958,984 | 3.64M |
| 333 | ZNTL | Zentalis Pharmaceuticals, Inc. | 138.57M | 1.90% | 638,101 | 26.87M |
| 334 | CDXS | Codexis, Inc. | 138.12M | -3.80% | 1,068,318 | 70.39M |
| 335 | ARTV | Artiva Biotherapeutics, Inc. | 134.71M | 8.78% | 177,928 | 251.00K |
| 336 | TNYA | Tenaya Therapeutics, Inc. | 134.54M | -6.78% | 3,479,510 | - |
| 337 | IMUX | Immunic, Inc. | 134.38M | -5.50% | 2,014,125 | - |
| 338 | FATE | Fate Therapeutics, Inc. | 131.38M | -3.42% | 864,657 | 6.65M |
| 339 | UNCY | Unicycive Therapeutics, Inc. | 131.31M | -4.38% | 613,076 | - |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 130.55M | -0.91% | 86,525 | 2.00M |
| 341 | SPRO | Spero Therapeutics, Inc. | 129.68M | -3.86% | 313,930 | 66.80M |
| 342 | HUMA | Humacyte, Inc. | 127.55M | -14.96% | 15,716,424 | 2.04M |
| 343 | AGEN | Agenus Inc. | 124.41M | -4.42% | 257,485 | 114.20M |
| 344 | ANTX | AN2 Therapeutics, Inc. | 124.36M | -5.46% | 254,886 | - |
| 345 | MIST | Milestone Pharmaceuticals Inc. | 123.88M | -2.88% | 2,141,094 | 1.55M |
| 346 | KLRS | Kalaris Therapeutics, Inc. | 121.52M | -1.67% | 25,864 | - |
| 347 | KPTI | Karyopharm Therapeutics Inc. | 119.48M | -3.28% | 829,649 | 146.07M |
| 348 | BDTX | Black Diamond Therapeutics, Inc. | 116.30M | - | 420,463 | 70.00M |
| 349 | ACOG | Alpha Cognition Inc. | 115.67M | 4.72% | 51,660 | 10.22M |
| 350 | IPHA | Innate Pharma S.A. | 115.51M | -3.08% | 17,170 | 10.57M |
| 351 | PMN | ProMIS Neurosciences, Inc. | 115.50M | -12.62% | 34,987 | - |
| 352 | INO | Inovio Pharmaceuticals, Inc. | 115.38M | 3.73% | 1,152,725 | 65.34K |
| 353 | SGMO | Sangamo Therapeutics, Inc. | 114.22M | -4.24% | 12,268,154 | 32.88M |
| 354 | EQ | Equillium, Inc. | 110.65M | -6.91% | 753,760 | 4.39M |
| 355 | CRDF | Cardiff Oncology, Inc. | 105.97M | - | 692,623 | 593.00K |
| 356 | HURA | TuHURA Biosciences, Inc. | 105.05M | -4.42% | 523,295 | - |
| 357 | GNLX | Genelux Corporation | 102.06M | -7.26% | 281,191 | 8.00K |
| 358 | ALDX | Aldeyra Therapeutics, Inc. | 101.11M | -5.08% | 1,900,482 | - |
| 359 | BMEA | Biomea Fusion, Inc. | 95.44M | - | 864,740 | - |
| 360 | TTRX | Turn Therapeutics Inc. | 94.81M | -6.94% | 33,622 | - |
| 361 | SEER | Seer, Inc. | 94.50M | 0.90% | 146,894 | 16.58M |
| 362 | COYA | Coya Therapeutics, Inc. | 88.67M | -4.55% | 128,871 | 7.95M |
| 363 | ONCY | Oncolytics Biotech Inc. | 86.62M | -4.17% | 580,383 | - |
| 364 | LONA | LeonaBio, Inc. | 86.50M | 3.29% | 40,037 | - |
| 365 | QTTB | Q32 Bio Inc. | 86.31M | -18.62% | 593,773 | 53.74M |
| 366 | MCRB | Seres Therapeutics, Inc. | 84.36M | -2.22% | 54,039 | 789.00K |
| 367 | ANIX | Anixa Biosciences, Inc. | 83.82M | -1.96% | 117,267 | - |
| 368 | FBIO | Fortress Biotech, Inc. | 83.80M | -2.17% | 1,208,310 | 62.30M |
| 369 | KZIA | Kazia Therapeutics Limited | 83.53M | 2.09% | 84,239 | 1.27M |
| 370 | VRCA | Verrica Pharmaceuticals Inc. | 81.77M | 8.68% | 68,731 | 35.58M |
| 371 | CSBR | Champions Oncology, Inc. | 81.10M | 1.74% | 7,051 | 57.95M |
| 372 | PYPD | PolyPid Ltd. | 80.34M | -1.64% | 72,546 | - |
| 373 | SPRB | Spruce Biosciences, Inc. | 80.31M | -7.15% | 33,625 | 697.00K |
| 374 | PYXS | Pyxis Oncology, Inc. | 79.80M | -3.05% | 156,714 | 13.86M |
| 375 | MAIA | MAIA Biotechnology, Inc. | 79.48M | - | 538,341 | - |
| 376 | AARD | Aardvark Therapeutics, Inc. | 79.41M | 2.54% | 185,087 | - |
| 377 | VANI | Vivani Medical, Inc. | 79.40M | -8.04% | 441,965 | - |
| 378 | OKYO | OKYO Pharma Limited | 79.24M | -1.31% | 108,386 | - |
| 379 | FLNA | Filana Therapeutics, Inc. | 78.26M | -2.99% | 391,723 | - |
| 380 | RANI | Rani Therapeutics Holdings, Inc. | 76.10M | -5.86% | 3,374,946 | 1.63M |
| 381 | GANX | Gain Therapeutics, Inc. | 76.04M | -1.64% | 488,676 | - |
| 382 | GOSS | Gossamer Bio, Inc. | 75.10M | -7.65% | 7,585,598 | 48.47M |
| 383 | NRXS | NeurAxis, Inc. | 73.95M | -4.20% | 146,733 | 3.57M |
| 384 | PLRX | Pliant Therapeutics, Inc. | 72.75M | 0.43% | 336,463 | - |
| 385 | ATYR | aTyr Pharma, Inc. | 71.67M | -2.81% | 1,476,315 | 190.00K |
| 386 | PTHS | Pelthos Therapeutics Inc. | 70.47M | -6.63% | 2,318 | 16.80M |
| 387 | XBIT | XBiotech Inc. | 69.21M | - | 22,680 | - |
| 388 | NRXP | NRx Pharmaceuticals, Inc. | 69.04M | -4.57% | 652,616 | 1.23M |
| 389 | CING | Cingulate Inc. | 67.91M | -8.61% | 374,057 | - |
| 390 | GUTS | Fractyl Health, Inc. | 67.74M | -4.81% | 2,368,544 | 3.00K |
| 391 | GRCE | Grace Therapeutics, Inc. | 67.47M | -6.64% | 477,718 | - |
| 392 | MNOV | MediciNova, Inc. | 66.94M | -1.45% | 19,950 | 409.66K |
| 393 | COEP | Coeptis Therapeutics Holdings, Inc. | 66.71M | 0.37% | 35,257 | 1.36M |
| 394 | BYSI | BeyondSpring Inc. | 66.61M | 1.25% | 24,864 | 1.88M |
| 395 | ACET | Adicet Bio, Inc. | 65.68M | -5.56% | 112,634 | - |
| 396 | PMVP | PMV Pharmaceuticals, Inc. | 65.06M | -6.87% | 454,371 | - |
| 397 | IBO | Impact BioMedical Inc. | 63.12M | 1.84% | 52,719 | 32.00K |
| 398 | EXOZ | eXoZymes, Inc. | 61.32M | 2.10% | 5,497 | -700.00 |
| 399 | IFRX | InflaRx N.V. | 60.13M | -8.79% | 326,680 | 34.44K |
| 400 | ATHE | Alterity Therapeutics Limited | 59.60M | 12.97% | 94,648 | 4.43M |
| 401 | DWTX | Dogwood Therapeutics, Inc. | 59.45M | -10.10% | 78,756 | - |
| 402 | IBIO | iBio, Inc. | 59.07M | -2.84% | 430,100 | 300.00K |
| 403 | ICCC | ImmuCell Corporation | 58.16M | -1.38% | 13,620 | 27.64M |
| 404 | ANVS | Annovis Bio, Inc. | 56.99M | -0.99% | 360,422 | - |
| 405 | IMA | ImageneBio, Inc. | 55.92M | - | 94,861 | 800.00K |
| 406 | LPCN | Lipocine Inc. | 55.33M | 6.01% | 134,784 | 1.98M |
| 407 | KZR | Kezar Life Sciences, Inc. | 54.92M | 20.16% | 1,083,531 | - |
| 408 | ACTU | Actuate Therapeutics, Inc. | 54.30M | 6.51% | 50,057 | - |
| 409 | TIL | Instil Bio, Inc. | 53.98M | 2.18% | 23,043 | - |
| 410 | TCRX | TScan Therapeutics, Inc. | 53.50M | -4.88% | 298,799 | 10.33M |
| 411 | CGTX | Cognition Therapeutics, Inc. | 53.13M | -18.56% | 4,862,654 | - |
| 412 | OKUR | OnKure Therapeutics, Inc. | 51.82M | -5.01% | 494,296 | - |
| 413 | HYFT | MindWalk Holdings Corp. | 50.66M | -4.67% | 318,063 | 20.70M |
| 414 | MREO | Mereo BioPharma Group plc | 50.44M | -3.98% | 1,192,959 | 500.00K |
| 415 | ACRV | Acrivon Therapeutics, Inc. | 49.98M | -3.01% | 587,964 | - |
| 416 | INKT | MiNK Therapeutics, Inc. | 49.38M | -4.54% | 83,242 | - |
| 417 | RADX | Radiopharm Theranostics Limited | 48.55M | 2.12% | 70,126 | 10.86M |
| 418 | RNXT | RenovoRx, Inc. | 48.24M | -5.31% | 343,094 | 928.00K |
| 419 | XLO | Xilio Therapeutics, Inc. | 47.62M | -1.02% | 13,543 | 43.77M |
| 420 | MGX | Metagenomi Therapeutics, Inc. | 47.59M | -4.17% | 323,795 | 25.21M |
| 421 | IMMP | Immutep Limited | 47.44M | -0.71% | 574,420 | 5.28M |
| 422 | OSTX | OS Therapies Incorporated | 46.84M | -5.67% | 478,337 | - |
| 423 | ENTX | Entera Bio Ltd. | 45.86M | -11.50% | 302,853 | 42.00K |
| 424 | LSTA | Lisata Therapeutics, Inc. | 45.25M | -0.20% | 78,122 | 170.00K |
| 425 | EDSA | Edesa Biotech, Inc. | 44.50M | -8.42% | 252,221 | - |
| 426 | ESLA | Estrella Immunopharma, Inc. | 43.95M | -1.90% | 13,103 | - |
| 427 | RLYB | Rallybio Corporation | 42.53M | -2.19% | 58,124 | 858.00K |
| 428 | NTRB | Nutriband Inc. | 42.06M | -10.36% | 8,945 | 2.28M |
| 429 | ALGS | Aligos Therapeutics, Inc. | 40.59M | -1.50% | 37,109 | 2.19M |
| 430 | ATOS | Atossa Therapeutics, Inc. | 40.56M | -0.21% | 39,160 | - |
| 431 | TELO | Telomir Pharmaceuticals, Inc. | 39.19M | -8.80% | 124,976 | - |
| 432 | HOWL | Werewolf Therapeutics, Inc. | 38.73M | 2.06% | 370,663 | 1.14M |
| 433 | LITS | Lite Strategy, Inc. | 37.82M | -5.45% | 362,231 | - |
| 434 | PSTV | Plus Therapeutics, Inc. | 36.81M | -6.70% | 3,689,869 | 5.21M |
| 435 | CELU | Celularity Inc. | 36.34M | 3.28% | 43,384 | 40.58M |
| 436 | PTN | Palatin Technologies, Inc. | 36.33M | -7.20% | 23,610 | 8.96M |
| 437 | NBY | NovaBay Pharmaceuticals, Inc. | 35.94M | -10.00% | 254,820 | 10.30M |
| 438 | APLM | Apollomics, Inc. | 35.86M | -3.24% | 3,428 | 6.93M |
| 439 | RNTX | Rein Therapeutics Inc. | 35.61M | 1.60% | 48,651 | - |
| 440 | ATRA | Atara Biotherapeutics, Inc. | 35.33M | -5.88% | 77,048 | 120.77M |
| 441 | NXTC | NextCure, Inc. | 35.25M | -1.10% | 61,842 | - |
| 442 | VERU | Veru Inc. | 34.19M | 1.91% | 37,048 | 16.89M |
| 443 | CRVO | CervoMed Inc. | 33.52M | -2.69% | 46,699 | 4.01M |
| 444 | PLUR | Pluri Inc. | 33.37M | 2.47% | 6,401 | 1.34M |
| 445 | SNSE | Sensei Biotherapeutics, Inc. | 31.80M | -9.21% | 72,597 | - |
| 446 | EVAX | Evaxion A/S | 31.44M | 7.10% | 37,540 | 7.53M |
| 447 | ATNM | Actinium Pharmaceuticals, Inc. | 30.88M | -3.88% | 171,093 | 90.00K |
| 448 | INMB | INmune Bio Inc. | 30.31M | 1.79% | 394,500 | 50.00K |
| 449 | TVRD | Tvardi Therapeutics, Inc. | 30.02M | 0.95% | 55,159 | - |
| 450 | PDSB | PDS Biotechnology Corporation | 29.36M | -0.91% | 492,240 | - |
| 451 | HYPD | Hyperion DeFi, Inc. | 28.74M | -6.43% | 531,838 | 813.46K |
| 452 | XCUR | Exicure, Inc. | 28.51M | 1.31% | 15,131 | 500.00K |
| 453 | LIXT | Lixte Biotechnology Holdings, Inc. | 27.27M | 1.29% | 40,816 | - |
| 454 | LGVN | Longeveron Inc. | 27.24M | 1.13% | 425,580 | 1.20M |
| 455 | BCTX | BriaCell Therapeutics Corp. | 27.02M | 10.13% | 147,855 | - |
| 456 | DARE | Daré Bioscience, Inc. | 26.64M | 18.06% | 415,220 | 1.03M |
| 457 | DYAI | Dyadic International, Inc. | 26.60M | 7.54% | 81,925 | 3.09M |
| 458 | KYNB | Kyntra Bio, Inc. | 26.14M | -1.97% | 49,210 | 6.44M |
| 459 | JSPR | Jasper Therapeutics, Inc. | 25.19M | -14.29% | 836,834 | - |
| 460 | AEON | AEON Biopharma, Inc. | 25.04M | -14.70% | 129,019 | - |
| 461 | CVM | CEL-SCI Corporation | 24.85M | -4.06% | 29,200 | - |
| 462 | IGC | IGC Pharma, Inc. | 24.48M | 0.08% | 151,330 | 1.11M |
| 463 | QNTM | Quantum BioPharma Ltd. | 24.47M | -10.27% | 2,267,903 | - |
| 464 | BOLD | Boundless Bio, Inc. | 24.42M | -1.80% | 124,742 | - |
| 465 | NRSN | NeuroSense Therapeutics Ltd. | 24.41M | - | 84,881 | - |
| 466 | ABVC | ABVC BioPharma, Inc. | 22.47M | -9.06% | 105,329 | 797.92K |
| 467 | BRNS | Barinthus Biotherapeutics plc | 22.47M | - | 4,066 | 14.97M |
| 468 | SER | Serina Therapeutics, Inc. | 22.17M | -20.70% | 654,492 | 130.00K |
| 469 | CUE | Cue Biopharma, Inc. | 22.07M | -5.60% | 422,041 | 27.47M |
| 470 | VTGN | Vistagen Therapeutics, Inc. | 21.62M | -4.15% | 360,162 | 789.00K |
| 471 | NEUP | Neuphoria Therapeutics Inc. | 21.24M | -3.90% | 74,432 | 14.99M |
| 472 | TPST | Tempest Therapeutics, Inc. | 21.19M | -12.14% | 204,170 | - |
| 473 | OTLK | Outlook Therapeutics, Inc. | 21.03M | -3.41% | 4,616,797 | 205.70K |
| 474 | MRKR | Marker Therapeutics, Inc. | 20.67M | -4.62% | 124,486 | 3.55M |
| 475 | CRIS | Curis, Inc. | 20.49M | -7.76% | 180,001 | 9.44M |
| 476 | SNTI | Senti Biosciences, Inc. | 20.29M | -2.32% | 176,010 | 22.00K |
| 477 | PASG | Passage Bio, Inc. | 19.82M | -3.13% | 14,158 | - |
| 478 | SKYE | Skye Bioscience, Inc. | 19.78M | 2.70% | 143,837 | - |
| 479 | VYNE | VYNE Therapeutics Inc. | 19.59M | -0.54% | 133,483 | 570.00K |
| 480 | LEXX | Lexaria Bioscience Corp. | 19.41M | 5.08% | 124,408 | 522.00K |
| 481 | PLRZ | Polyrizon Ltd. | 18.94M | -1.00% | 17,346 | - |
| 482 | NNVC | NanoViricides, Inc. | 18.79M | -4.06% | 91,202 | - |
| 483 | TVGN | Tevogen Bio Holdings Inc. | 17.37M | -1.72% | 17,968 | - |
| 484 | ALLR | Allarity Therapeutics, Inc. | 16.72M | -2.80% | 58,907 | - |
| 485 | KTTA | Pasithea Therapeutics Corp. | 16.51M | -3.38% | 37,056 | - |
| 486 | CTXR | Citius Pharmaceuticals, Inc. | 15.22M | -5.37% | 311,434 | 3.94M |
| 487 | GNTA | Genenta Science S.p.A. | 14.76M | -11.23% | 53,361 | - |
| 488 | ICU | SeaStar Medical Holding Corporation | 14.46M | 32.12% | 1,798,654 | 1.23M |
| 489 | INTS | Intensity Therapeutics, Inc. | 14.43M | -5.80% | 14,195 | - |
| 490 | TRAW | Traws Pharma, Inc. | 13.98M | -0.57% | 16,684 | 2.85M |
| 491 | PHIO | Phio Pharmaceuticals Corp. | 13.94M | -4.76% | 527,276 | - |
| 492 | LTRN | Lantern Pharma Inc. | 13.81M | 10.27% | 3,876,735 | - |
| 493 | COCP | Cocrystal Pharma, Inc. | 13.78M | -2.91% | 77,629 | - |
| 494 | OSRH | OSR Holdings, Inc. | 13.58M | 13.84% | 1,217,611 | -90.52K |
| 495 | INAB | IN8bio, Inc. | 13.49M | -2.84% | 42,268 | - |
| 496 | GTBP | GT Biopharma, Inc. | 13.07M | 1.32% | 410,545 | - |
| 497 | BCAB | BioAtla, Inc. | 12.76M | 0.52% | 608,871 | 11.00M |
| 498 | BCDA | BioCardia, Inc. | 12.69M | - | 73,012 | 3.00K |
| 499 | IOBT | IO Biotech, Inc. | 12.40M | -10.67% | 1,117,901 | - |
| 500 | MBRX | Moleculin Biotech, Inc. | 11.95M | -8.20% | 115,191 | - |